HTRS2025.P1.2 Effect of Baseline Target Joints on Annualized Bleeding Rate and Management of Breakthrough Bleeding in Patients With Hemophilia A or B and Inhibitors: Results From Concizumab Phase 3 Explorer7

Emily Waters, Amy Shapiro, Ana Boban, Renée Brown Frandsen, Silvia Linari, Johnny Mahlangu, Emily Waters, Camila Martins Mazini Tavares, Tadashi Matsushita, Salim Nekkal, Jameela Sathar, Anthony Chan

Open source

DOI
10.1016/j.rpth.2025.103022
Published
2025-11
Container
Research and Practice in Thrombosis and Haemostasis
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.rpth.2025.103022,
  title = {HTRS2025.P1.2 Effect of Baseline Target Joints on Annualized Bleeding Rate and Management of Breakthrough Bleeding in Patients With Hemophilia A or B and Inhibitors: Results From Concizumab Phase 3 Explorer7},
  author = {Emily Waters and Amy Shapiro and Ana Boban and Renée Brown Frandsen and Silvia Linari and Johnny Mahlangu and Emily Waters and Camila Martins Mazini Tavares and Tadashi Matsushita and Salim Nekkal and Jameela Sathar and Anthony Chan},
  year = {2025},
  journal = {Research and Practice in Thrombosis and Haemostasis},
  doi = {10.1016/j.rpth.2025.103022},
  url = {https://doi.org/10.1016/j.rpth.2025.103022}
}

RIS

TY  - JOUR
TI  - HTRS2025.P1.2 Effect of Baseline Target Joints on Annualized Bleeding Rate and Management of Breakthrough Bleeding in Patients With Hemophilia A or B and Inhibitors: Results From Concizumab Phase 3 Explorer7
AU  - Emily Waters
AU  - Amy Shapiro
AU  - Ana Boban
AU  - Renée Brown Frandsen
AU  - Silvia Linari
AU  - Johnny Mahlangu
AU  - Emily Waters
AU  - Camila Martins Mazini Tavares
AU  - Tadashi Matsushita
AU  - Salim Nekkal
AU  - Jameela Sathar
AU  - Anthony Chan
PY  - 2025
JO  - Research and Practice in Thrombosis and Haemostasis
DO  - 10.1016/j.rpth.2025.103022
UR  - https://doi.org/10.1016/j.rpth.2025.103022
ER  - 

APA

Waters, E., Shapiro, A., Boban, A., Frandsen, R. B., Linari, S., Mahlangu, J., Waters, E., Tavares, C. M. M., Matsushita, T., Nekkal, S., Sathar, J., & Chan, A. (2025). HTRS2025.P1.2 Effect of Baseline Target Joints on Annualized Bleeding Rate and Management of Breakthrough Bleeding in Patients With Hemophilia A or B and Inhibitors: Results From Concizumab Phase 3 Explorer7. Research and Practice in Thrombosis and Haemostasis. https://doi.org/10.1016/j.rpth.2025.103022

Source records